Health insurers are still planning to cover the hepatitis B vaccine at no cost to patients after the Centers for Disease Control and Prevention’s advisory panel voted to narrow its recommendations, but it’s unclear whether employers will follow suit.
The Advisory Committee on Immunization Practices’ vote Friday curtailing its decades-old recommendation that all newborn infants receive a vaccine for hepatitis B is another step toward Health and Human Services Secretary Robert F. Kennedy Jr.’s aim to roll back the number of immunizations Americans receive.
While major insurers have pledged to maintain the status quo—at least in the short-term—that doesn’t apply ...